Diana Rodriguez Rivera
Dermatology · Cayey, PRNPI 1902209612
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,880 of the $4,474 with a category attached, or 86.7%. 17 manufacturers reported payments, led by AbbVie at 28.8% of the total. Reporting peaked in 2022 at $1,264 and has fallen 64.7% since, to $446 in 2025.
Across 144 payments — averaging $31.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$941
- Johnson & Johnson$374
- PBG Puerto Rico LLC$256
- E.r. Squibb & Sons, L.L.C.$255
- Eli Lilly Export S.A. Puerto Rico Branch$238
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,88087%
- Education$59413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $1,288 |
| Sanofi | 29 | $941 |
| Johnson & Johnson(2 entities) | 10 | $374 |
| PBG Puerto Rico LLC | 12 | $256 |
| E.r. Squibb & Sons, L.L.C. | 6 | $255 |
| Eli Lilly Export S.A. Puerto Rico Branch | 12 | $238 |
| LEO Pharma Inc. | 5 | $233 |
| Sanofi-aventis U.S. LLC | 3 | $230 |
| Genentech USA, Inc. | 5 | $204 |
| Revance Therapeutics, Inc. | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Amgen | 5 | $94 |
| Pfizer | 2 | $50 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Novartis | 1 | $19 |
| Organon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,474 in reported general payments places this provider in the 70th percentile of 108 dermatology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 330 | $6,945 |
| Betamethasone Valerate | 143 | $6,076 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 119 | $5,382 |
| Fluorouracil | 50 | $4,097 |
| Ciclopirox | 105 | $3,313 |
| Metronidazole | 46 | $2,961 |
| Calcipotriene | 25 | $2,616 |
| Desonide | 62 | $2,250 |
| Clindamycin Phosphate | 46 | $2,129 |
| Clobetasol Propionate | 46 | $2,076 |
| Triamcinolone Acetonide | 187 | $2,035 |
| Tacrolimus | 26 | $1,860 |
| Betamethasone Dipropionate | 39 | $1,547 |
| Permethrin | 13 | $790 |
| Ammonium Lactate | 24 | $598 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cayey
- Jose Gonzalez ChavezSan Juan$248K
- Rafael Martin GarciaSan Juan$199K
- Noelani Gonzalez-OrtizSan Juan$154K
- Alma Cruz SantanaCarolina$74K
- Eneida de la TorreBayamon$39K
- Samuel SanchezCaguas$25K
- Elena Montalvan MiroSan Juan$20K
- Luis Ortiz EspinosaBayamon$18K
- Hiram RuizArecibo$17K
- Pedro Vendrell BenitoPonce$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.